Stericycle Analyst Ratings
Stericycle Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/01/2023 | 58.34% | Stifel | → $70 | Reiterates | Buy → Buy |
| 06/14/2023 | 49.29% | RBC Capital | → $66 | Reiterates | Outperform → Outperform |
| 06/02/2023 | 49.29% | RBC Capital | → $66 | Reiterates | Outperform → Outperform |
| 05/01/2023 | 49.29% | RBC Capital | → $66 | Reiterates | → Outperform |
| 04/18/2023 | 1.79% | Truist Securities | → $45 | Initiates Coverage On | → Hold |
| 02/24/2023 | 19.88% | Baird | $65 → $53 | Downgrades | Outperform → Neutral |
| 08/08/2022 | 58.34% | RBC Capital | $82 → $70 | Maintains | Outperform |
| 05/12/2022 | — | Berenberg | Downgrades | Buy → Hold | |
| 02/25/2022 | 62.86% | Baird | $77 → $72 | Maintains | Outperform |
| 11/06/2020 | 67.38% | BMO Capital | $68 → $74 | Maintains | Market Perform |
| 08/17/2020 | 17.62% | B of A Securities | $44 → $52 | Maintains | Underperform |
| 05/13/2020 | -0.48% | B of A Securities | $52 → $44 | Reiterates | → Underperform |
| 05/08/2020 | 51.55% | RBC Capital | $75 → $67 | Maintains | Outperform |
| 04/08/2020 | 58.34% | Stifel | $73 → $70 | Maintains | Buy |
| 02/20/2020 | 69.64% | Baird | $65 → $75 | Maintains | Neutral |
| 11/22/2019 | 69.64% | RBC Capital | → $75 | Initiates Coverage On | → Outperform |
| 11/22/2019 | 53.81% | Jefferies | → $68 | Initiates Coverage On | → Hold |
| 08/02/2019 | -0.48% | Baird | → $44 | Upgrades | Underperform → Neutral |
| 04/18/2019 | — | Baird | Downgrades | Neutral → Underperform | |
| 03/04/2019 | 1.79% | BMO Capital | $41 → $45 | Maintains | Market Perform |
| 03/01/2019 | — | Goldman Sachs | Upgrades | Neutral → Buy | |
| 12/19/2018 | -0.48% | Baird | $56 → $44 | Maintains | Neutral |
| 11/06/2018 | 15.36% | BMO Capital | $58 → $51 | Maintains | Market Perform |
| 11/02/2018 | 13.1% | B of A Securities | $53 → $50 | Maintains | Underperform |
| 11/02/2018 | 26.67% | Baird | $70 → $56 | Maintains | Neutral |
| 10/23/2018 | 19.88% | B of A Securities | → $53 | Initiates Coverage On | → Underperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 09/01/2023 | 58.34% | Stifel | →$70 | 重申 | 購買→購買 |
| 2023/06/14 | 49.29% | 加拿大皇家銀行資本 | →$66 | 重申 | 跑贏→跑贏大盤 |
| 06/02/2023 | 49.29% | 加拿大皇家銀行資本 | →$66 | 重申 | 跑贏→跑贏大盤 |
| 05/01/2023 | 49.29% | 加拿大皇家銀行資本 | →$66 | 重申 | →跑贏大盤 |
| 04/18/2023 | 1.79% | Truist證券 | →$45 | 開始承保 | →保留 |
| 02/24/2023 | 19.88% | 貝爾德 | $65→$53 | 評級下調 | 跑贏→中性 |
| 2022/08/08 | 58.34% | 加拿大皇家銀行資本 | $82→$70 | 維護 | 跑贏大盤 |
| 2022年05月12日 | - | 貝倫伯格 | 評級下調 | 購買→Hold | |
| 02/25/2022 | 62.86% | 貝爾德 | $77→$72 | 維護 | 跑贏大盤 |
| 11/06/2020 | 67.38% | 蒙特利爾銀行資本 | $68→$74 | 維護 | 市場表現 |
| 2020/08/17 | 17.62% | B of A證券 | $44→$52 | 維護 | 表現不佳 |
| 2020/05/13 | -0.48% | B of A證券 | $52→$44 | 重申 | →表現不佳 |
| 05/08/2020 | 51.55% | 加拿大皇家銀行資本 | $75→$67 | 維護 | 跑贏大盤 |
| 04/08/2020 | 58.34% | Stifel | $73→$70 | 維護 | 買 |
| 02/20/2020 | 69.64% | 貝爾德 | $65→$75 | 維護 | 中性 |
| 2019年11月22日 | 69.64% | 加拿大皇家銀行資本 | →$75 | 開始承保 | →跑贏大盤 |
| 2019年11月22日 | 53.81% | 傑富瑞 | →$68 | 開始承保 | →保留 |
| 2019年08月02日 | -0.48% | 貝爾德 | →$44 | 升級 | 表現不佳的→中性 |
| 2019/04/18 | - | 貝爾德 | 評級下調 | 中性→表現不佳 | |
| 2019/03/04 | 1.79% | 蒙特利爾銀行資本 | $41→$45 | 維護 | 市場表現 |
| 2019年03月01日 | - | 高盛 | 升級 | 中性→購買 | |
| 2018年12月19日 | -0.48% | 貝爾德 | $56→$44 | 維護 | 中性 |
| 2018/06/11 | 15.36% | 蒙特利爾銀行資本 | $58→$51 | 維護 | 市場表現 |
| 11/02/2018 | 13.1% | B of A證券 | $53→$50 | 維護 | 表現不佳 |
| 11/02/2018 | 26.67% | 貝爾德 | $70→$56 | 維護 | 中性 |
| 2018年10月23日 | 19.88% | B of A證券 | →$53 | 開始承保 | →表現不佳 |
What is the target price for Stericycle (SRCL)?
立體自行車(SRCL)的目標價是多少？
The latest price target for Stericycle (NASDAQ: SRCL) was reported by Stifel on September 1, 2023. The analyst firm set a price target for $70.00 expecting SRCL to rise to within 12 months (a possible 58.34% upside). 6 analyst firms have reported ratings in the last year.
Stifel於2023年9月1日報道了納斯達克(Stifel)的最新目標價。這家分析公司將目標價定為70.00美元，預計SRCL將在12個月內上漲(可能上漲58.34%)。6家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for Stericycle (SRCL)?
分析師對Stericycle(SRCL)的最新評級是多少？
The latest analyst rating for Stericycle (NASDAQ: SRCL) was provided by Stifel, and Stericycle reiterated their buy rating.
納斯達克(Stifel)最新的分析師評級是由Stifel提供的，Stericycle重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for Stericycle (SRCL)?
下一次發佈或更新對立體自行車(SRCL)的分析師評級是什麼時候？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Stericycle, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Stericycle was filed on September 1, 2023 so you should expect the next rating to be made available sometime around September 1, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Stericycle的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。對自行車的最後一次評級是在2023年9月1日提交的，所以你應該預計下一次評級將在2024年9月1日左右的某個時候公佈。
Is the Analyst Rating Stericycle (SRCL) correct?
分析師評級為立體自行車(SRCL)正確嗎？
While ratings are subjective and will change, the latest Stericycle (SRCL) rating was a reiterated with a price target of $0.00 to $70.00. The current price Stericycle (SRCL) is trading at is $44.21, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的立體車(SRCL)評級被重申，目標價在0.00美元至70.00美元之間。目前立體自行車(SRCL)的交易價格為44.21美元，在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。